Wayne Gattinella CEO DeBogy Molecular, Inc.
Landmark Study Reveals the Promise of Infection-Free Medical Implantation is Near: By Wayne Gattinella CEO DeBogy Molecular
Gattinella advises, "The demand for bacteria-free surfaces continues to increase—and there is no greater need for a sterile, antibacterial surface than with a biomedical device or implant." Read on to learn more.